Startup Dossier
Osivax
A company developing "universal" vaccines able to prevent highly mutating respiratory viral infections.
active
Typestartup
SectorBioTech
LocationLyon
About
A company developing "universal" vaccines able to prevent highly mutating respiratory viral infections.
Structural DNA
Legal Name
Osivax
SIREN
829604750
Founders & Team
Funding Lineage
Series B
Meiji Seika Pharma (Lead)
€10.0M
Mar 2025